ROYCE & ASSOCIATES LP

Position in ANGO — Angiodynamics Inc

CIK 906304 New York, NY

Position in ANGO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,627,553

+$8,243,381 QoQ

Shares Held

1,969,835

+28.8% QoQ

Ownership

4.77%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

of 162 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $221,060,137 across 12 Medical Instruments & Supplies names. ANGO ranks #3 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AVTR	Avantor, Inc.	3,676,084	$36,393,231
2	NVST	Envista Holdings Corp	1,270,717	$33,483,392
3	ANGO	Angiodynamics Inc This page	1,969,835	$25,627,553
4	RGEN	Repligen Corp	174,794	$23,848,893
5	AZTA	Azenta, Inc.	891,419	$22,749,012
6	BLFS	Biolife Solutions Inc	623,875	$17,618,230
7	STVN	Stevanato Group S.p.A.	916,356	$16,558,552
8	COO	Cooper Companies, Inc.	223,879	$16,054,363

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,627,553	1,969,835	+28.8%	Shares	Sole	2026-08-14
2026-03-31	$17,384,172	1,528,951	+20.6%	Shares	Sole	2026-05-12
2025-12-31	$16,274,070	1,267,451	+27.3%	Shares	Sole	2026-02-09
2025-09-30	$11,118,171	995,360	+1.7%	Shares	Sole	2025-11-12
2025-06-30	$9,707,315	978,560	-4.8%	Shares	Sole	2025-08-11
2025-03-31	$9,649,445	1,027,630	-8.2%	Shares	Sole	2025-05-06
2024-12-31	$10,253,566	1,119,385	+13.5%	Shares	Sole	2025-02-10
2024-09-30	$7,671,647	986,073	+10.8%	Shares	Sole	2024-11-06
2024-06-30	$5,384,106	889,935	+72.8%	Shares	Sole	2024-08-13
2024-03-31	$3,022,668	514,935	+187.3%	Shares	Sole	2024-05-13
2020-09-30	$2,161,453	179,225	-49.3%	Shares	Sole	2020-11-12
2020-06-30	$3,593,772	353,370	-9.9%	Shares	Sole	2020-08-07
2020-03-31	$4,089,018	392,044	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.